BioXcel Therapeutics (BTAIQ) Asset Utilization Ratio (2022 - 2026)
BioXcel Therapeutics' Asset Utilization Ratio came in at 0.02 for Q2 2026, down 12.4% from 0.03 a year earlier but up 37.1% from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Going back to Q3 2022, BioXcel Therapeutics' Asset Utilization Ratio data covers 16 quarters.
- Going back by year, Asset Utilization Ratio was 0.04 in FY2024 (+309.7%), 0.01 in FY2023 (+486.2%) and 0.00 in FY2022.
- The five-year range for quarterly Asset Utilization Ratio is 0.00 (Q3 2022) to 0.05 (Q4 2024).
- Year-over-year, Asset Utilization Ratio has declined for five consecutive quarters, with growth averaging 51.8% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q4 2023 (growth of 852.3%), and the weakest in Q4 2025 (a decline of 72.5%).
- Business Quant data shows BTAIQ's Asset Utilization Ratio at 0.02 (Q1 2026), 0.01 (Q4 2025) and 0.02 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | 0.02 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.02 |
| Mar 31, 2026 | 0.02 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | 0.05 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
API Access
BioXcel Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();